Standard cognitive screening thresholds may exclude many patients with biomarker-confirmed atypical Alzheimer’s disease despite early-stage functional impairment, new data show.

Older adults in Sardinian Blue Zone communities who took more daily steps, spent less time sedentary, perceived their ...

Atypical Alzheimer's disease treatment eligibility is blocked for up to 85% of patients by a cognitive test never designed ...

Many people with atypical Alzheimer disease (AD) do not meet eligibility criteria for anti-amyloid therapies (AAT), according ...

A 10-year study of 1,003 older adults linked cognitive super-aging to fewer emergency visits, unplanned hospital admissions, ...

A new study found that blood thinners called NOACs may slow cognitive decline in people with Alzheimer's who have atrial ...

Creyos, a leader in digital cognitive and behavioral health assessment, today announced initial results from its rollout with Claremedica, a value-based senior primary care organization serving over ...

Exercise and healthy blood sugar levels in midlife may help slow cognitive decline decades later. Physical activity appeared ...

Patients with early Alzheimer’s disease treated with diranersen experienced slower cognitive decline and greater reductions ...

Many people with less common forms of Alzheimer's disease may not qualify for newer anti-amyloid treatments designed to slow ...

Physical activity and controlling blood sugar in midlife are associated with a significantly slower rate of cognitive decline ...

Many people with atypical Alzheimer’s disease may be ruled out from early anti-amyloid treatment despite still functioning ...